Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Monogram Orthopaedics Inc ( (MGRM) ) has provided an update.
On July 26, 2025, Monogram Technologies Inc. performed the world’s first fully autonomous saw-based robotic knee replacement surgery using their mBôs TKA System at Krishna Shalby Hospital in Ahmedabad, India. This groundbreaking procedure is part of a multi-center clinical trial in India, marking a significant milestone for the company and potentially revolutionizing the standard of care in orthopedic medicine. The trial, supported by strategic partner Shalby Limited, involves 102 total knee replacement procedures and aims to evaluate the safety and effectiveness of the Monogram TKA System. The successful execution of this surgery highlights the potential impact of Monogram’s technology on the industry, with implications for global clinical practices.
The most recent analyst rating on (MGRM) stock is a Buy with a $4.00 price target. To see the full list of analyst forecasts on Monogram Orthopaedics Inc stock, see the MGRM Stock Forecast page.
Spark’s Take on MGRM Stock
According to Spark, TipRanks’ AI Analyst, MGRM is a Neutral.
Monogram Orthopaedics Inc. shows promise due to significant technological advancements and recent regulatory clearances, which are key drivers for potential growth. However, financial instability, regulatory uncertainties, and ongoing profitability challenges weigh heavily on the overall score. The stock’s upward momentum is a positive indicator, but valuation metrics remain weak due to negative earnings and lack of dividends.
To see Spark’s full report on MGRM stock, click here.
More about Monogram Orthopaedics Inc
Monogram Technologies Inc. is an AI-driven robotics company focused on improving human health, particularly in orthopedic surgery. The company is developing a product solution architecture that combines 3D printing, advanced machine vision, AI, and next-generation robotics to enable patient-optimized orthopedic implants at scale.
Average Trading Volume: 342,713
Technical Sentiment Signal: Buy
For detailed information about MGRM stock, go to TipRanks’ Stock Analysis page.